EcoDrugPlus

Ensembl ID : ENSPSNG00000013418
Gene Symbol: -
Cross references: -
171 Possible Orthologues:

Ensembl ID : ENSPSNG00000003208
Gene Symbol: -
Cross references: -
261 Possible Orthologues:

Ensembl ID : ENSPSNG00000002111
Gene Symbol: -
Cross references: -
167 Possible Orthologues:

Ensembl ID : ENSPSNG00000013752
Gene Symbol: -
Cross references: -
166 Possible Orthologues:

Ensembl ID : ENSPSNG00000013786
Gene Symbol: -
Cross references: -
224 Possible Orthologues:

Ensembl ID : ENSPSNG00000014607
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSPSNG00000001190
Gene Symbol: -
Cross references: -
311 Possible Orthologues:

Ensembl ID : ENSPSNG00000000654
Gene Symbol: -
Cross references: -
262 Possible Orthologues:

Ensembl ID : ENSPSNG00000017846
Gene Symbol: -
Cross references: -
241 Possible Orthologues:

Ensembl ID : ENSPSNG00000016414
Gene Symbol: -
Cross references: -
137 Possible Orthologues:

Ensembl ID : ENSPSNG00000015071
Gene Symbol: -
Cross references: -
92 Possible Orthologues:

Ensembl ID : ENSPSNG00000014161
Gene Symbol: -
Cross references: -
231 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).